1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Predictive Disease Analytics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Predictive Disease Analytics Market, by Component
8.1.1 Software & Services
8.1.1.1. Market Revenue and Forecast
8.1.2. Hardware
8.1.2.1. Market Revenue and Forecast
9.1. Predictive Disease Analytics Market, by Deployment
9.1.1. On-premises
9.1.1.1. Market Revenue and Forecast
9.1.2. Cloud-based
9.1.2.1. Market Revenue and Forecast
10.1. Predictive Disease Analytics Market, by End Users
10.1.1. Healthcare Payers
10.1.1.1. Market Revenue and Forecast
10.1.2. Healthcare Providers
10.1.2.1. Market Revenue and Forecast
10.1.3. Other
10.1.3.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Component
11.1.2. Market Revenue and Forecast, by Deployment
11.1.3. Market Revenue and Forecast, by End Users
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component
11.1.4.2. Market Revenue and Forecast, by Deployment
11.1.4.3. Market Revenue and Forecast, by End Users
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component
11.1.5.2. Market Revenue and Forecast, by Deployment
11.1.5.3. Market Revenue and Forecast, by End Users
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component
11.2.2. Market Revenue and Forecast, by Deployment
11.2.3. Market Revenue and Forecast, by End Users
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component
11.2.4.2. Market Revenue and Forecast, by Deployment
11.2.4.3. Market Revenue and Forecast, by End Users
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component
11.2.5.2. Market Revenue and Forecast, by Deployment
11.2.5.3. Market Revenue and Forecast, by End Users
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component
11.2.6.2. Market Revenue and Forecast, by Deployment
11.2.6.3. Market Revenue and Forecast, by End Users
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component
11.2.7.2. Market Revenue and Forecast, by Deployment
11.2.7.3. Market Revenue and Forecast, by End Users
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component
11.3.2. Market Revenue and Forecast, by Deployment
11.3.3. Market Revenue and Forecast, by End Users
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component
11.3.4.2. Market Revenue and Forecast, by Deployment
11.3.4.3. Market Revenue and Forecast, by End Users
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component
11.3.5.2. Market Revenue and Forecast, by Deployment
11.3.5.3. Market Revenue and Forecast, by End Users
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component
11.3.6.2. Market Revenue and Forecast, by Deployment
11.3.6.3. Market Revenue and Forecast, by End Users
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component
11.3.7.2. Market Revenue and Forecast, by Deployment
11.3.7.3. Market Revenue and Forecast, by End Users
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component
11.4.2. Market Revenue and Forecast, by Deployment
11.4.3. Market Revenue and Forecast, by End Users
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component
11.4.4.2. Market Revenue and Forecast, by Deployment
11.4.4.3. Market Revenue and Forecast, by End Users
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component
11.4.5.2. Market Revenue and Forecast, by Deployment
11.4.5.3. Market Revenue and Forecast, by End Users
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component
11.4.6.2. Market Revenue and Forecast, by Deployment
11.4.6.3. Market Revenue and Forecast, by End Users
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component
11.4.7.2. Market Revenue and Forecast, by Deployment
11.4.7.3. Market Revenue and Forecast, by End Users
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component
11.5.2. Market Revenue and Forecast, by Deployment
11.5.3. Market Revenue and Forecast, by End Users
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component
11.5.4.2. Market Revenue and Forecast, by Deployment
11.5.4.3. Market Revenue and Forecast, by End Users
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component
11.5.5.2. Market Revenue and Forecast, by Deployment
11.5.5.3. Market Revenue and Forecast, by End Users
12.1. IBM Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. SAS Institute Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Optum, Inc. (a subsidiary of UnitedHealth Group)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cerner Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. McKesson Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Allscripts Healthcare Solutions, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Oracle Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Microsoft Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Health Catalyst, LLC
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Epic Systems Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
